Beyond CA125, other biomarkers on the way

New biomarkers are coming to detect recurrent ovarian cancer and may be helpful some day to screen women as well. Patient scan read about HE4 at Fujirebio Diagnostics  to understand what the current use and availability of this marker of ovarian cancer is. For now pelvic exams and ultrasounds, with judicial use of the biomarker CA125 is still what is offered as effective screening for women at risk or women with symptoms of ovarian cancer.  


Popular posts from this blog

Passing Your Uterine Lining, Menstrual Period Norms

Mirena IUD and Your Sex Drive

Post-Endometrial Ablation Syndrome